Mr Jayanth K Gutta, MD | |
950 S Main St, Suite 3, Celina, OH 45822-2479 | |
(419) 586-3017 | |
(419) 586-3174 |
Full Name | Mr Jayanth K Gutta |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 45 Years |
Location | 950 S Main St, Celina, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558308957 | NPI | - | NPPES |
2631370 | Medicaid | OH |
Facility Name | Location | Facility Type |
---|---|---|
Mercer County Joint Township Community Hospital | Coldwater, OH | Hospital |
Grand Lake Health System | Saint marys, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
M E D F Physicians Corporation | 9133109903 | 43 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
Pediatricians have called for a ban on the sale of mothballs containing the chemical naphthalene citing evidence that these can lead to severe blood problems and even brain damage for significant numbers of Australian babies.
Wis. Gov. Scott Walker officially announced on Wednesday that he will not implement a state-based health exchange or accept federal funding for it. Meanwhile, in Minnesota, a government task force has begun debating a list of basic principles for that state's health care exchange. And Stateline offers an overview of what states in general are doing in regard to these insurance marketplaces.
A new analysis of current data indicates that remdesivir does not show efficacy in regulating the severity of the illness.
› Verified 3 days ago
Entity Name | M E D F Physicians Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417992710 PECOS PAC ID: 9133109903 Enrollment ID: O20040722000452 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
Pediatricians have called for a ban on the sale of mothballs containing the chemical naphthalene citing evidence that these can lead to severe blood problems and even brain damage for significant numbers of Australian babies.
Wis. Gov. Scott Walker officially announced on Wednesday that he will not implement a state-based health exchange or accept federal funding for it. Meanwhile, in Minnesota, a government task force has begun debating a list of basic principles for that state's health care exchange. And Stateline offers an overview of what states in general are doing in regard to these insurance marketplaces.
A new analysis of current data indicates that remdesivir does not show efficacy in regulating the severity of the illness.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Jayanth K Gutta, MD 950 S Main St, Suite 3, Celina, OH 45822-2479 Ph: (567) 890-7138 | Mr Jayanth K Gutta, MD 950 S Main St, Suite 3, Celina, OH 45822-2479 Ph: (419) 586-3017 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced it has completed the rolling submission of the New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA).
Pediatricians have called for a ban on the sale of mothballs containing the chemical naphthalene citing evidence that these can lead to severe blood problems and even brain damage for significant numbers of Australian babies.
Wis. Gov. Scott Walker officially announced on Wednesday that he will not implement a state-based health exchange or accept federal funding for it. Meanwhile, in Minnesota, a government task force has begun debating a list of basic principles for that state's health care exchange. And Stateline offers an overview of what states in general are doing in regard to these insurance marketplaces.
A new analysis of current data indicates that remdesivir does not show efficacy in regulating the severity of the illness.
› Verified 3 days ago
Shanthi Nmi Satyanarayana, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 950 S Main St, Ste 2, Celina, OH 45822 Phone: 419-586-1618 Fax: 419-586-9886 | |
Dr. Neal Evan Holleran, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 329 1/2 E. Market St., Celina, OH 45822 Phone: 419-584-1664 Fax: 419-584-0693 | |
Dr. Wilfred J.g. Ellis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 950 S Main St Ste A, Celina, OH 45822 Phone: 419-586-9657 | |
Jerry Joe Boley, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4112 Monroe Rd, Celina, OH 45828 Phone: 614-580-8563 |